Skadden represented PT Prodia Widyahusada Tbk, Indonesia's largest clinical laboratory company, in its 1.5 trillion rupiah ($111 million) Regulation S combined primary/secondary initial public offering of common shares and listing on the Indonesia Stock Exchange.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates